Explorer les evidences

11 017 patients11,017 patients were enrolled in an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

Malaria was more prevalent in children without HIV.

Ghanapaludismepublié 2018Malaria journalPubMeddocument de 4 observations

324 per_1000The malaria incidence averted was 324 per 1,000 children aged 12–59 months in 2020 in the implementing area.

Ghanapaludismeobservé 2020publié 2024Malaria journalPubMeddocument de 4 observations

490 cases_averted_per_1000_full_dose_equivalentsIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 RTS,S full-dose equivalents at month 32 post-dose 1, was 490 for group R012-14-26.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

287 per_1000The malaria incidence averted was 287 per 1,000 children aged 12–59 months in 2022 in the implementing area.

Ghanapaludismeobservé 2022publié 2024Malaria journalPubMeddocument de 4 observations

28 %The prevalence of placental malaria was 28.0% among 2646 pregnant women with malaria in Burkina Faso, Ghana, Malawi, and Zambia.

Burkina Faso · Ghana · Malawi · Zambiepaludismepublié 2019Malaria journaleurope_pmcdocument de 6 observations

0,41 %A 1% increase in malaria morbidity reduces economic growth by 0.41% in Ghana.

GhanapaludismeHAL · Unilimdocument de 40 observations

Three sub-Saharan African countries — Ghana, Kenya, and Malawi — participated in a large-scale clinical study supervised by the WHO to assess the feasibility of vaccination against malaria in children.

Ghana · Kenya · MalawipaludismeHAL · Unilimdocument de 84 observations

11 097 patientsA total of 11,097 patients were screened for confirmed uncomplicated malaria in an observational study conducted in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

38 %In a phase 2b trial in Ghana and Kenya, vaccine efficacy of the RTS,S malaria vaccine against clinical malaria (all episodes) at month 32 post-dose 1 ranged from 38% (95% confidence interval: 24%–49%) to 53% (95% confidence interval: 42%–62%).

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

74,7 %In Ghana, prevalence of hemoglobin genotypes was 74.7% for AA, 14.7% for AC, 9.1% for AS, and 0.9% for SS.

GhanapaludismeHAL · Unilimdocument de 81 observations

7,12 nMArtemether was less potent against Plasmodium malariae than Plasmodium falciparum in Ghana, with IC50 values of 7.12 nM versus 2.15 nM.

Ghanapaludismepublié 2025Microbiology spectrumeurope_pmcdocument de 5 observations

2 112 cases_averted_per_1000_childrenIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 children vaccinated at month 32 post-dose 1, was 2112 for group Fx017-20-32.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

12,7 %Plasmodium malariae was detected in 12.7% of the 142 malaria-positive participants in Mpraeso, Ghana.

Ghanapaludismeobservé 2014publié 2017Malaria journalPubMeddocument de 4 observations

25 %Malaria parasitemia prevalence was 25% among people living with HIV in the rural area of Atibie, Ghana.

Ghanapaludismepublié 2018Acta tropicaPubMeddocument de 4 observations

2 450 cases_averted_per_1000_childrenIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 children vaccinated at month 32 post-dose 1, was 2450 for group R012-14-26.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

47,9 %In Ghana, malaria prevalence among pregnant women at first antenatal care visit was 47.9% (622 of 1298).

Ghanapaludismeobservé between May, 2010, and August, 2014PubMeddocument de 8 observations

874 cases_averted_per_1000_full_dose_equivalentsIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 RTS,S full-dose equivalents at month 32 post-dose 1, was 874 for group Fx012-14-26.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

96,1 %96.1% of enrolled patients met protocol requirements for analysis in an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

Ghana, Kenya, and Malawi were the first countries to introduce the RTS,S/AS01 malaria vaccine into their childhood immunization programmes in 2019 as part of a pilot programme called the Malaria Vaccine Implementation Programme (MVIP).

Ghana · Kenya · Malawipaludismeobservé 2019publié 2025Malaria journalPubMeddocument de 2 observations

445 000 deathsIn 2016, there were an estimated 445,000 malaria deaths.

Ghanapaludismeobservé 2016HAL · Unilimdocument de 40 observations

10,38 nMAtovaquone was less potent against Plasmodium malariae than Plasmodium falciparum in Ghana, with IC50 values of 10.38 nM versus 2.51 nM.

Ghanapaludismepublié 2025Microbiology spectrumeurope_pmcdocument de 5 observations

332 patients332 patients withdrew from an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

2 273 cases_averted_per_1000_childrenIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 children vaccinated at month 32 post-dose 1, was 2273 for group Fx012-14-26.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

55 %In Ghana, the household is responsible for 55% of the malaria treatment cost.

GhanapaludismeHAL · Unilimdocument de 40 observations